Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Aug 7;9(8):2560. doi: 10.3390/jcm9082560

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Surface under the cumulative ranking curves (SUCRAs) vs. rank. (A), change in forced vital capacity % of predicted (FVC %); (B), change in diffusion lung capacity for CO % of predicted (DLCO %); (C), number of patients with serious adverse events (SAEs); (D), number of patients discontinuing treatment for adverse events (AEs); (E), deaths. Treatments have been ranked according to SUCRAs. For example, in (A), rituximab is the treatment with the highest probability of being the best (RANK 1) having the highest SUCRA (95.7). (C–E), treatment with the best rank are those with better tolerability, safety, and lower number of deaths, respectively.